Back To TOP

Connect to Compass for Patient Access Find the right patient assistance program for your patients

Is your patient insured?

Patient Background

Patient Background

Back

Patient Assessment

Patient Assessment

Back

Patient Assistance Programs

Patient Assistance Programs

Back

Genentech BioOncology Co-pay Card

This program can help reduce your patients’ out-of-pocket expenses associated with their prescriptions.

Click here to learn more about the BioOncology Co-pay Card.

Back

Back

I don't know

Patient Assistance Programs Tailored to Your Patients’ Needs

Each patient’s insurance and financial situation is unique. XELODA Access Solutions offers a full range of programs and services to meet the needs of your patients and your practice.

Uninsured patients Genentech® Access to Care Foundation
Publicly or privately insured patients Referrals to co-pay assistance foundations

For complete eligibility criteria or information on how to get started with these programs, click here.

Back

Back

Co-pay Assistance Foundations

Co-pay Assistance

If patients need help with their medication co-pays, XELODA Access Solutions can connect them to a co-pay assistance foundation supporting their disease state.

Click here to learn more about co-pay assistance foundations.

Back

Back

About GATCF

We believe insurance coverage should not be a barrier to treatment. In support of that belief and our commitment to patients, Genentech® Access to Care Foundation (GATCF) offers Genentech medicine free of charge to qualified patients who don’t have insurance.

Click here to learn more about GATCF

Back

Back

Your Answer:

Start Over
  • Answer Eligibility Questions
  • Assess Eligibility
  • Find a Solution
Learn More About
XELODA
  • LEARN about treatment with XELODA
  • FIND the right patient assistance program with our Compass for Patient Access tool
  • Form Statement of Medical Necessity
  • Form Patient Authorization and Notice of Release of Information

The Access Solutions logo is a registered trademark of Genentech, Inc.